Karyopharm Therapeutics appoints Garen Bohlin to its Board of Directors

– USA – Natick, MA – Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced the appointment of Garen Bohlin to its board of directors, effective immediately.…